Search Login Register

Hyperglycemia Summary

Description: Abnormally high BLOOD GLUCOSE level.

Also Known As: Hyperglycemia, Postprandial; Hyperglycemias; Hyperglycemias, Postprandial; Postprandial Hyperglycemias; Postprandial Hyperglycemia

Networked: 18979 relevant articles (1020 outcomes, 1892 trials/studies) for this Disease

Key Drugs and Agents for Hyperglycemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Insulin (Novolin) : 319 outcomes 389 studies in 5217 results : FDA 2
  2. Glucose (Dextrose) : 236 outcomes 471 studies in 5375 results : FDA 175 Generic
  3. Streptozocin (Streptozotocin) : 50 outcomes 128 studies in 991 results : FDA 1
  4. Blood Glucose (Blood Sugar) : 30 outcomes 88 studies in 1127 results : IBA
  5. Metformin (Glucophage) : 20 outcomes 12 studies in 162 results : FDA 4 Generic
  6. Glucagon-Like Peptide 1 (GLP 1) : 18 outcomes 18 studies in 165 results : IBA
  7. Glucagon (Glukagon) : 14 outcomes 34 studies in 538 results : FDA 4
  8. Alloxan : 14 outcomes 34 studies in 264 results : IBA
  9. Acarbose : 14 outcomes 7 studies in 84 results : FDA 4 Generic
  10. Enzymes : 12 outcomes 17 studies in 185 results : IBA
Show All >>

Diseases Related to Hyperglycemia

  1. Insulin Resistance
  2. Hyperinsulinism (Hyperinsulinemia)
  3. Hyperlipidemias (Hyperlipidemia)
  4. Hypoglycemia (Reactive Hypoglycemia)
  5. Body Weight (Weight, Body)
Show All >>

Key Therapies for Hyperglycemia

Efficacy Chart >>
  1. Transplantation (Transplant Recipients) : 14 outcomes 23 studies in 216 results
  2. Oral Administration : 13 outcomes 7 studies in 58 results
  3. Transplants (Transplant) : 11 outcomes 22 studies in 230 results
  4. Drug Therapy (Chemotherapy) : 9 outcomes 7 studies in 89 results
  5. Injections : 5 outcomes 5 studies in 108 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.